Trials / Recruiting
RecruitingNCT06945718
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)
Prospective Trials on Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With D2 Extra-regional Lymph Node Dissection for Locally Advanced Gastric Cancer (FUGES-30)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 760 (estimated)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Taking patients with locally advanced gastric adenocarcinoma (cT2-4a, N-/+, M0) as the research subjects, to evaluate whether the clinical efficacy of laparoscopic beyond D2 regional lymph node dissection for gastric cancer with indocyanine green tracer is better or not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | beyond D2 regional lymph node dissection | dissect the lymph nodes outside the extent of D2 LN region. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2027-04-01
- Completion
- 2030-05-01
- First posted
- 2025-04-25
- Last updated
- 2025-05-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06945718. Inclusion in this directory is not an endorsement.